How Your Thyroid Controls Your Testosterone (Check This Before TRT)

Your testosterone might be low because your thyroid is broken. Not your testes. Not your pituitary sending the wrong signal. Your thyroid, sitting upstream of everything, quietly failing to give the rest of the system what it needs to work.

Here is why that matters, and why most clinics will never tell you.

Your body runs three major hormonal systems, and all three route through the same control center in your brain. You have a region called the hypothalamus, and directly below it sits the pituitary gland. Together, they act as the relay station for your thyroid axis, your testosterone axis, and your growth hormone axis. Each axis follows the same basic pattern: your brain sends a signal down to a gland, that gland produces a hormone, and that hormone feeds back up to tell your brain whether to send more or less signal. Because all three axes share this same infrastructure, they influence each other. And because they share infrastructure, there is an order of operations.

Thyroid is first. Testosterone is second. Growth hormone is third.

So when something goes wrong in the thyroid axis, the downstream systems do not just receive less support. They receive a fundamentally altered signal environment.

The thyroid axis starts with your hypothalamus releasing something called TRH, which is thyrotropin releasing hormone, and this travels down to the pituitary, which responds by releasing TSH, which is thyroid stimulating hormone. TSH then travels to your thyroid gland and tells it to produce thyroid hormones. Your thyroid produces two of them. T4, called thyroxine, makes up about 80% of total output, and T3, called triiodothyronine, makes up the remaining 20%. T4 is the storage form and T3 is the active form, meaning T4 has to be converted before your body can actually use it. That conversion is done by enzymes called deiodinases, and those enzymes require selenium to function.

Think of it like a factory. T4 is raw material sitting in the warehouse, deiodinase enzymes are the workers converting it into finished product, and T3 is the finished product your cells can actually use. If the workers are undermanned because selenium is low, raw material piles up and usable output drops. Winther and colleagues confirmed this directly, finding that selenium deficiency is associated with a measurably high T4 to T3 ratio, meaning conversion is impaired and active hormone is running short.

There is also a bypass that makes this worse. T4 can be converted into something called reverse T3, which is an inactive form that actually competes with real T3 for receptor binding without doing any of the work T3 does. Chronic cortisol, as Chopra and colleagues showed in 1975, shifts T4 metabolism toward reverse T3 within hours. So a person under sustained stress can have normal TSH, normal T4, and still be functionally hypothyroid because their active T3 is being converted away before it can reach its targets.

Standard testing catches none of this. TSH tells you whether your brain thinks the thyroid is producing enough. It does not tell you whether T4 is converting properly, whether reverse T3 is accumulating, or whether the active hormone is actually getting to the tissues that need it. That gap between what standard testing shows and what is actually happening in the tissue is called functional hypothyroidism, and it is the mechanism behind a significant amount of unexplained low testosterone.

Here is how the connection works at the cellular level.

The first point of interference is the pituitary itself. T3 modulates how well the pituitary responds to GnRH, which is the signal your hypothalamus sends to trigger testosterone production. In a hypothyroid state, the GnRH signal arrives but the pituitary produces an inadequate LH response. The relay is too weak. Donnelly and White studied this directly in men with primary hypothyroidism and found that free testosterone nearly doubled after thyroxine replacement, rising from 161 to 315 pmol/L. The pattern was hypogonadotropic, meaning low testosterone with low or inappropriately normal LH, which tells you the problem was at the relay station, not at the testes.

The second point is directly at the Leydig cells, which are the cells in your testes that manufacture testosterone. These cells have thyroid hormone receptors on them, and T3 does two things there. It increases the number of LH receptors on the cell surface, making the cell more sensitive to whatever signal it is receiving, and it upregulates something called StAR protein, which is steroidogenic acute regulatory protein, and this is the rate limiting step in testosterone production because it is the protein responsible for transporting cholesterol into the mitochondria where the actual synthesis begins. Maran and colleagues measured this and found that T3 induced a 260% increase in StAR expression in Leydig cells. Your thyroid hormone is controlling how much raw material gets into the testosterone factory at the most fundamental possible step.

The third mechanism involves something called SHBG, which is sex hormone binding globulin, and this is a protein your liver produces that binds to testosterone and makes it biologically unavailable. Thyroid status affects how much SHBG your liver produces, which means that two men with the same total testosterone number can have very different amounts of usable testosterone depending entirely on their thyroid function. This is why SHBG has to be part of any complete hormonal picture.

A conference abstract by Shrivastav and Saboo looked at 51 men with overt hypothyroidism and found that 50% had low testosterone at baseline, and that after normalizing thyroid function with levothyroxine, 70% of those men had their testosterone return to normal without any testosterone replacement at all. This is a conference abstract, not a peer reviewed trial, so the evidence is preliminary, but the direction is consistent with the Donnelly data and with every mechanism described above.

The growth hormone connection extends this further. Your pituitary contains cells called somatotrophs that produce growth hormone, and these cells need adequate T3 to express the receptors that receive the growth hormone releasing signal from your hypothalamus. Miki and colleagues demonstrated that hypothyroidism depressed the growth hormone response to GHRH and that T3 treatment restored it. More directly relevant to anyone using peptides: the growth hormone secretagogue receptor, which is the receptor that compounds like ipamorelin and MK-677 target, is regulated by T3. Kamegai and colleagues showed in 2001 that T3 increases the expression of this receptor by extending its mRNA half life from 8 hours to 15 hours. That study used rat pituitary cells in vitro, so direct human translation is not confirmed, but the mechanism suggests that if your T3 is low, you have fewer of the receptors your peptides are trying to activate, which would explain why some people get no response even at documented effective doses.

So before any bloodwork makes sense, you need the right bloodwork. TSH alone is not enough. You need TSH, free T3, free T4, and reverse T3 on the thyroid side, and total testosterone, free testosterone, LH, and SHBG on the hormonal side. LH specifically tells you whether you are dealing with a problem at the testicular level or a problem at the relay station, and that distinction determines what the solution actually is.

If thyroid function is suboptimal but not overtly pathological, there are addressable inputs. Selenium at 200 micrograms per day supports deiodinase activity and T4 to T3 conversion, with a ceiling of 400 micrograms where toxicity begins. Zinc at 30 milligrams daily is required for TRH synthesis and thyroid hormone receptor function. Iron is a component of thyroid peroxidase, the enzyme your thyroid uses to produce T4 and T3 in the first place, and Hess and colleagues showed that iron deficiency reduced thyroid peroxidase activity by 33 to 56% in rats. Iodine is the literal building block of both T4 and T3, but supplementing without confirmed deficiency can worsen autoimmune thyroid conditions like Hashimoto's, so that one requires testing first.

Hashimoto's thyroiditis, the most common cause of hypothyroidism, is autoimmune and cannot be corrected with nutritional support. True hypothyroidism with elevated TSH and low free thyroid hormones requires levothyroxine under medical supervision, and over replacement creates its own set of problems including bone loss, cardiac arrhythmia, and anxiety, which is why working with a physician who runs a full panel is not optional here.

The practical implication of everything above is this: a doctor who checks your testosterone, sees a low number, and hands you a prescription has identified the symptom and skipped the diagnosis. They have seen that the building has no electricity and recommended rewiring, without first checking whether the foundation is poured correctly. You would not start with the wiring.

The thyroid axis is not a footnote to testosterone optimization. It is the upstream condition that determines whether testosterone optimization is even possible, and whether the signal you are trying to amplify has anywhere to go.

---

References

1. Donnelly P, White C. 2000. Testicular dysfunction in men with primary hypothyroidism; reversal of hypogonadotrophic hypogonadism with replacement thyroxine. Clinical Endocrinology, 522:197-201. Free testosterone nearly doubled 161 to 315 pmol/L after thyroxine replacement in hypothyroid men. Source
2. Shrivastav A, Saboo B. 2022. Effect of levothyroxine replacement therapy on testosterone, LH, FSH levels in men with overt hypothyroidism. ECE2022 Conference Abstract, Endocrine Abstracts, 81, P730. 70% of hypogonadal hypothyroid patients had testosterone normalize after levothyroxine. Conference abstract, N=51. Source
3. Maran RR, et al. 2000. Assessment of mechanisms of thyroid hormone action in mouse Leydig cells. Endocrinology, 14112:4468-4477. T3 increases LH receptor numbers, StAR protein 260% increase, and steroidogenic enzyme expression in Leydig cells. Source
4. Kamegai J, et al. 2001. Thyroid hormones regulate pituitary growth hormone secretagogue receptor gene expression. Journal of Neuroendocrinology, 133:275-278. T3 increased GHS-R mRNA by extending half-life from 8h to 15h in rat pituitary cells. Source
5. Miki N, et al. 1989. Effects of hypothyroidism, T3 and glucocorticoids on GH responses to GHRH. Journal of Endocrinology, 122:585-591. Hypothyroidism depressed growth hormone response to GHRH; T3 treatment restored it. Source
6. Winther KH, et al. 2020. Thyroid function in patients with selenium deficiency exhibits high free T4 to T3 ratio. BMC Endocrine Disorders. Selenium deficiency directly associated with impaired T4 to T3 conversion. Source
7. Hess SY, et al. 2002. Iron deficiency anemia reduces thyroid peroxidase activity in rats. Journal of Nutrition, 1327:1951-1955. Iron deficiency reduced TPO activity by 33-56%. Source
8. Chopra IJ, et al. 1975. Opposite effects of dexamethasone on serum concentrations of reverse T3 and T3. Journal of Clinical Endocrinology and Metabolism. Cortisol shifts T4 metabolism toward reverse T3 within hours. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness